Yüklüyor......
Effects of Evogliptin as Add on in Type 2 Diabetes (T2DM) Subjects Inadequately Controlled With Metformin and Glimepiride Combination
Objective: To achieve targeted glycemic control people with diabetes required multiple drug therapy. We retrospectively studied effect of adding newly approved DPP4i evogliptin in T2DM subjects having high HbA1c value despite being on tolerable stable doses of Metformin and Glimepiride. Methods: We...
Kaydedildi:
| Yayımlandı: | J Endocr Soc |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8266189/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.957 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|